BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10610208)

  • 1. GnRH analogs and uterine artery embolization.
    Hutchins FL; Worthington-Kirsch R; Berkowitz RP
    J Am Assoc Gynecol Laparosc; 1999 Aug; 6(3):367-8. PubMed ID: 10610208
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of gonadotropin-releasing hormone agonist treatment upon angiogenesis in uterine leiomyoma.
    Abulafia O; Kleinhaus K; Levi G; Lee YC; Sherer DM
    Gynecol Obstet Invest; 2001; 52(2):108-13. PubMed ID: 11586038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative GnRH analog treatment for the prevention of recurrences of uterine myomas after myomectomy. A pilot study.
    Vavala V; Lanzone A; Monaco A; Scribanti A; Guida C; Mancuso S
    Gynecol Obstet Invest; 1997; 43(4):251-4. PubMed ID: 9194624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience in the treatment of fibroids with leuprolide and other GnRH agonists.
    Friedman AJ
    Obstet Gynecol Surv; 1989 May; 44(5):311-3. PubMed ID: 2498793
    [No Abstract]   [Full Text] [Related]  

  • 5. Preoperative use of GnRH agonist for leiomyomas.
    Hutchins FL
    J Reprod Med; 1997 Apr; 42(4):253. PubMed ID: 9131502
    [No Abstract]   [Full Text] [Related]  

  • 6. Magnetic resonance imaging of leiomyomata uteri: assessing therapy with the gonadotropin-releasing hormone agonist leuprolide.
    Lubich LM; Alderman MG; Ros PR
    Magn Reson Imaging; 1991; 9(3):331-4. PubMed ID: 1908932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of uterine fibroids: current findings with gonadotropin-releasing hormone agonists.
    Adamson GD
    Am J Obstet Gynecol; 1992 Feb; 166(2):746-51. PubMed ID: 1531577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of premedication with gonadotropin releasing hormone agonists before transcervical resection of solitary submucous myoma].
    Römer T
    Gynakol Geburtshilfliche Rundsch; 1996; 36(4):194-6. PubMed ID: 9206552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient selection for laparoscopic myomectomy.
    Parker WH; Rodi IA
    J Am Assoc Gynecol Laparosc; 1994 Nov; 2(1):23-6. PubMed ID: 9050528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of circulating monocyte chemoattractant protein-1 in women with gonadotropin-releasing hormone agonist.
    Matsui S; Yasui T; Uemura H; Yamamoto S; Matsuzaki T; Tsuchiya N; Yuzurihara M; Kase Y; Irahara M
    J Reprod Immunol; 2011 Aug; 90(2):227-34. PubMed ID: 21726903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopic uterine artery occlusion versus uterine fibroid embolization.
    Holub Z; Mara M; Eim J
    Int J Gynaecol Obstet; 2007 Jan; 96(1):44-5. PubMed ID: 17188272
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of uterine fibroids.
    al-Taher H; Farquharson RG
    Br J Hosp Med; 1993 Jul 14-Aug 17; 50(2-3):133-6. PubMed ID: 8353665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasonographic prediction of the efficacy of GnRH agonist therapy before laparoscopic myomectomy.
    Zullo F; Pellicano M; Di Carlo C; De Stefano R; Marconi D; Zupi E
    J Am Assoc Gynecol Laparosc; 1998 Nov; 5(4):361-6. PubMed ID: 9782139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical practice. Uterine fibroids.
    Stewart EA
    N Engl J Med; 2015 Apr; 372(17):1646-55. PubMed ID: 25901428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semiquantitative assessment of MR imaging in prediction of efficacy of gonadotropin-releasing hormone agonist for volume reduction of uterine leiomyoma: initial experience.
    Okuda S; Oshio K; Shinmoto H; Tanimoto A; Asada H; Fujii T; Yoshimura Y; Kuribayashi S
    Radiology; 2008 Sep; 248(3):917-24. PubMed ID: 18710984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a gonadotropin-releasing hormone agonist to manage perimenopausal women with symptomatic uterine myomas.
    Wang PH; Lee WL; Cheng MH; Yen MS; Chao KC; Chao HT
    Taiwan J Obstet Gynecol; 2009 Jun; 48(2):133-7. PubMed ID: 19574174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative uterine artery embolization (PUAE) before uterine fibroid myomectomy.
    Dumousset E; Chabrot P; Rabischong B; Mazet N; Nasser S; Darcha C; Garcier JM; Mage G; Boyer L
    Cardiovasc Intervent Radiol; 2008; 31(3):514-20. PubMed ID: 17624572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine necrosis after uterine artery embolization for leiomyoma.
    Pelage JP; Walker WJ; Dref OL
    Obstet Gynecol; 2002 Apr; 99(4):676-7; author reply 677. PubMed ID: 12039135
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of GnRH analogs in hysteroscopic surgery].
    Celis R
    Rev Chil Obstet Ginecol; 1994; 59(2):153-7. PubMed ID: 7659801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neodymium: YAG laser hysteroscopy in large submucous fibroids.
    Donnez J; Gillerot S; Bourgonjon D; Clerckx F; Nisolle M
    Fertil Steril; 1990 Dec; 54(6):999-1003. PubMed ID: 2245860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.